Integration of scRNA ‐Seq and scATAC ‐Seq Reveals Malignant Characteristics of Sarcomatoid Clear Cell Renal Cell Carcinoma
Cancer Science · 2025
DOI: 10.1111/cas.70220 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Science, 2025. Verfasst von Wenhao Lu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, Guangxi, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms, Single-Cell Analysis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Natural Science Foundation of Guangxi Zhuang Autonomous Region, China Postdoctoral Science Foundation, Youth Science Foundation of Guangxi Medical University.
Abstract (Originalsprache)
Clear cell renal cell carcinoma (ccRCC) with sarcomatoid differentiation is a rare histological type of ccRCC, characterized by aggressive clinical behavior and poor prognosis. However, the malignant characteristics of this disease have yet to be fully elucidated. Here, we performed single‐cell RNA sequencing (scRNA‐seq), single‐cell assay for transposase‐accessible chromatin using sequencing (scATAC‐seq), and WES analysis on a single patient with sarcomatoid ccRCC. By integrating scRNA‐seq and scATAC‐seq data from 19 previous classical ccRCC samples (19,819 tumor cells and 21,684 nuclei), we firstly identified the transcriptional regulatory features of sarcomatoid differentiated tumor cells by scATAC‐seq, primarily evidenced by active binding with FOS / JUND , FOSL1 / JUN , and FOSL2 . In addition, we identified DST , FRMD4A , and PREX2 as tumor markers for ccRCC with sarcomatoid differentiation, which were validated in a cohort study. Moreover, we determined that PREX2 played a malignant role in ccRCC with sarcomatoid differentiation in vitro and in vivo, facilitating tumor progression by inhibiting PTEN and activating the PI3K/AKT pathway. This study demonstrated the comprehensive gene expression and DNA regulation information of ccRCC with sarcomatoid differentiation, highlighting its malignant characteristics, thereby offering novel insights for the diagnosis and treatment of sarcomatoid ccRCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, The First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, Guangxi, China.
- Center for Genomic and Personalized Medicine, Guangxi Key Laboratory for Genomic and Personalized Medicine, Guangxi Collaborative Innovation Center for Genomic and Personalized Medicine, Guangxi Medical University, Nann…
- Institute of Urology and Nephrology, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, Guangxi, China.
- Guangxi Key Laboratory of Precision Medicine in Cardio-Cerebrovascular Diseases Control and Prevention, First Affiliated Hospital of Guangxi Medical University, Guangxi Medical University, Nanning, Guangxi, China.
ORCID-Profile: Zhenyuan Yu
Förderung
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
- China Postdoctoral Science Foundation
- Youth Science Foundation of Guangxi Medical University
Zitieren
APA
Lu, W., Liu, Y., Cen, J., Huang, S., Wen, Z., Li, J., Mo, Z., Liang, X., Lu, Z., Su, C., & Yu, Z. (2025). Integration of scRNA ‐Seq and scATAC ‐Seq Reveals Malignant Characteristics of Sarcomatoid Clear Cell Renal Cell Carcinoma. Cancer Science. https://doi.org/10.1111/cas.70220
Vancouver
Lu W, Liu Y, Cen J, Huang S, Wen Z, Li J, et al. Integration of scRNA ‐Seq and scATAC ‐Seq Reveals Malignant Characteristics of Sarcomatoid Clear Cell Renal Cell Carcinoma. Cancer Science. 2025. doi:10.1111/cas.70220
BibTeX
@article{Lu2025,
author = {Lu, Wenhao and Liu, Yixuan and Cen, Jizhen and Huang, Shengzhu and Wen, Zheng and Li, Jiaping and Mo, Zengnan and Liang, Xuefang and Lu, Zheng and Su, Cheng and Yu, Zhenyuan},
title = {Integration of scRNA ‐Seq and scATAC ‐Seq Reveals Malignant Characteristics of Sarcomatoid Clear Cell Renal Cell Carcinoma},
journal = {Cancer Science},
year = {2025},
doi = {10.1111/cas.70220}
}
EUVIMED